Introduction
Introduction

Ferroportin 1 (FPN1) is an iron exporter expressed in a spectrum of tissues including liver, duodenum and in reticuloendothelial macrophages
. It has been identified as a major modulator of mammalian iron balance [5, 6] since mutations in FPN1 cause haemochromatosis [6] . In addition, hepcidin has been proposed to bind to FPN1, causing internalization and degradation of FPN1, and consequently bringing about a decrease in enteric absorption of inorganic iron [7] . FPN1 is expressed on the basolateral plasma membrane of enterocytes [2, 8] and has been suggested to mediate export of iron out of intestinal epithelial cells [9] . Hephaestin is required for this action [10] . FPN1 mRNA and protein have been detected in kidney [1, 3] , yet the renal function of FPN1 is currently obscure. [11] [12] [13] .
Previously, we have shown that divalent metal transporter 1 (DMT1) is expressed in proximal tubule (PT) late endosomes and lysosomes and that in vivo DMT1 expressed in the PT is strongly modulated in response to changes in dietary iron. We have suggested that following receptor mediated endocytosis of transferrin filtered by the glomerulus, PT DMT1 contributes to the transit of iron across the PT epithelium by exporting iron, liberated from transferrin, across the late endosomal/lysosomal membranes into the cytoplasm
The possibility that in the healthy organism iron is filtered by the glomerulus has for many years been disregarded due to the fact that transferrin has an exceptionally high binding affinity for iron and iron bound to transferrin is not filtered. This fact is also the seat of considerable dispute over the notion of non-transferrin bound iron.
However, in recent years evidence has come to light suggesting that some transferrin and iron actually make it through the glomerular filter [14] [15] [16] [17] [18] . Furthermore, cubilin and transferrin receptor 1, both effective in binding and internalizing transferrin, have been shown to be expressed on the apical, post-glomerular urine facing, membrane of PT cells [19, 20] . One interpretation of these findings is that a new as yet undefined system exists in PT cells for reabsorbing protein bound iron filtered by the glomerulus [21] . An essential part of this mechanism is suggested to be a means of translocating iron across the basolateral membrane (BLM) of PT cells [21] . FPN1 located on the BLM of PT cells could potentially fulfil this role. 
Ferroportin 1 is expressed basolaterally in rat kidney proximal tubule cells and iron excess increases its membrane trafficking
Methods
RT-PCR
Total RNA extraction and reverse transcription were as previously described [12] . Following [22] . [11] .
Xenopus oocytes expression
Preparation of membrane fractions and immunoblotting
Crude membrane samples were prepared from male Sprague-Dawley rat kidney or duodenum as previously described [11] . For isolation of BLMs from rat renal cortex two protocols were combined [24, 25] [28] .
Immunofluorescence labelling of FPN1 of cultured cells
For immunofluorescence labelling of FPN1 in fixed and permeabilized cells the method was as described previously [12] [29] .
Cell culture
An immortalized cell line from the S1-segment of rat PT (WKPT-0293 Cl.2) [30] was cultured as previously described [13] . Cells were passaged (passage number Ͻ41) twice a week upon reaching confluence.
Iron-loading and -depletion protocols
One day after cell plating (24 hrs) , medium was exchanged for complete culture medium containing either 100 M of ferric ammonium citrate (FAC) or desferrioxamine (DF) and incubated for 36 hrs [31, 32] .
Cellular iron content
Iron content of control, FAC-and DF-treated WKPT-0293 Cl.2 cells was essentially performed as described elsewhere [33, 34] [2, 8] (Fig. S1E) Fig. 2A) . At higher magnification, FPN1 immunoreactivity was observed on the basal membrane and what appeared to be the inside of PT cells (Fig. 2B and C) . This pattern of staining was evident in the S1, S2 and S3 segments of the PT (Fig. 2D and E) . Staining appeared to be most prominent (Fig. 2F-H (Fig. 3A) , FPN1 protein by immunoblotting of total cell homogenates (Fig. 4A ) and immunofluorescence staining of fixed and permeabilized confluent cells (Fig. 3B) . Therefore, FPN1 is also expressed in the WKPT-0293 Cl. 2 [11, 37] (Fig. 3C, upper panel, and 3D ). Experiments without primary antibody confirmed that staining was specific (Fig. 3C, lower panel) . (Fig. 4A and B [1] [2] [3] [4] .
cells. We then investigated whether changes in the iron status of the cultured PT cells affected FPN1. WKPT-0293 Cl.2 cells were exposed to 100 M FAC for 36 hrs to encourage iron-loading or DF for the same period to promote iron-depletion. FAC significantly increased total cellular iron content by about 600% compared to controls. DF treatment significantly reduced total cellular iron content by ~25% (see 'Methods'). Neither FAC nor DF affected FPN1 mRNA expression (data not shown). Similarly total FPN1 protein expression was not affected by any of the treatments (Fig. 4A). This is in contrast to expression of DMT1, where DMT1 protein was found to be reduced by iron loading (data not shown), and as previously demonstrated in vivo
. However, FAC treatment resulted in a dramatic increase of FPN1 surface localization, as demonstrated by immunofluorescence staining of nonpermeabilized WKPT-0293 Cl.2 cells, whereas DF had no effect
Discussion
FPN1 is an iron transport protein that is expressed in several tissues including duodenum, liver and macrophages. It functions as an iron exporter and has been suggested to be a major point of control of iron entry into the circulating transferrin bound iron pool
FPN1 mRNA or protein has been detected in kidney [1] [2] [3] [21] . [11] . Extracellular addition of transferrin to the apical membrane results in uptake of transferrin, followed by trafficking of transferrin to late endosomes and lysosomes where it colocalizes with DMT1 [11, 12] . We suggest that this mechanism represents the entry route of transferrin bound iron taken up from the urine, possible in the first instance by transferrin receptor 1 and or cubilin expressed in the apical brush border [19, 20] 
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